Literature DB >> 18356156

High rate of resistance to locally used antibiotics among enteric bacteria from children in Northern Ghana.

Andrea Djie-Maletz1, Klaus Reither, Stephen Danour, Louis Anyidoho, Eiman Saad, Francis Danikuu, Peter Ziniel, Thomas Weitzel, Jutta Wagner, Ulrich Bienzle, Klaus Stark, Andrew Seidu-Korkor, Frank P Mockenhaupt, Ralf Ignatius.   

Abstract

OBJECTIVES: Information on antimicrobial susceptibility of bacterial pathogens is scarce in resource-poor settings. We determined the susceptibility of bacterial enteric pathogens and faecal Escherichia coli isolates obtained from children in urban Tamale, Northern Ghana, to antibiotics widely used in the that area [ampicillin or amoxicillin, trimethoprim/sulfamethoxazole (SXT) and chloramphenicol] and to alternative drugs.
METHODS: Five Shigella spp., 6 Salmonella spp. and 318 E. coli were isolated from stool specimens obtained from 367 children with or without acute diarrhoea. Isolates were differentiated using standard laboratory procedures and tested using a breakpoint microbroth dilution method for their susceptibility to 18 antimicrobials and by disc diffusion for their susceptibility to chloramphenicol.
RESULTS: Although the salmonellae showed an acceptable resistance pattern, E. coli isolates and the closely related shigellae were highly resistant. About 91% and 81% of E. coli isolates from patients or controls, respectively, were resistant to ampicillin (MICs > or = 8 mg/L), 88% and 76% to trimethoprim/sulfamethoxazole (MICs > or = 80/4 mg/L) and 46% and 41% to chloramphenicol (inhibition zones < or = 12 mm). Resistance to beta-lactam antibiotics or chloramphenicol was observed more frequently among isolates obtained from infants when compared with older children (1-4 years of age).
CONCLUSIONS: Enteric bacteria from children in urban Northern Ghana are highly resistant to antibiotics used in that area. Therefore, new antibiotics should be introduced for the treatment of infections caused by these bacteria. Additionally, the establishment of a surveillance of the prevalence of the main bacterial infectious agents and their antimicrobial resistance is desirable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356156     DOI: 10.1093/jac/dkn108

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  25 in total

1.  Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale.

Authors:  Gilles Bourdin; Bertrand Schmitt; Laure Marvin Guy; Jacques-Edouard Germond; Sophie Zuber; Lise Michot; Gloria Reuteler; Harald Brüssow
Journal:  Appl Environ Microbiol       Date:  2013-12-20       Impact factor: 4.792

2.  A 9-year study of shigellosis in Northeast Malaysia: Antimicrobial susceptibility and shifting species dominance.

Authors:  Kirnpal-Kaur Banga Singh; Suvash Chandra Ojha; Zakuan Zainy Deris; Rosliza Abdul Rahman
Journal:  Z Gesundh Wiss       Date:  2010-11-19

3.  Risk factors for antibiotic-resistant E. coli in children in a rural area.

Authors:  J C Seidman; P Anitha K; R Kanungo; A L Bourgeois; C L Coles
Journal:  Epidemiol Infect       Date:  2008-11-12       Impact factor: 2.451

Review 4.  Comparison of resistance to third-generation cephalosporins in Shigella between Europe-America and Asia-Africa from 1998 to 2012.

Authors:  B Gu; M Zhou; X Ke; S Pan; Y Cao; Y Huang; L Zhuang; G Liu; M Tong
Journal:  Epidemiol Infect       Date:  2015-01-02       Impact factor: 4.434

5.  Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS).

Authors:  Norbert G Schwarz; Nimako Sarpong; Frank Hünger; Florian Marks; Samuel Ek Acquah; Alex Agyekum; Bernard Nkrumah; Wibke Loag; Ralf M Hagen; Jennifer A Evans; Denise Dekker; Julius N Fobil; Christian G Meyer; Jürgen May; Yaw Adu-Sarkodie
Journal:  BMC Infect Dis       Date:  2010-11-04       Impact factor: 3.090

6.  Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use.

Authors:  Adebayo Lamikanra; Jennifer L Crowe; Rebeccah S Lijek; Babatunde W Odetoyin; John Wain; A Oladipo Aboderin; Iruka N Okeke
Journal:  BMC Infect Dis       Date:  2011-11-07       Impact factor: 3.090

7.  Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element.

Authors:  Amy S Labar; Jennifer S Millman; Ellen Ruebush; Japheth A Opintan; Rima A Bishar; A Oladipo Aboderin; Mercy J Newman; Adebayo Lamikanra; Iruka N Okeke
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  A unified approach to molecular epidemiology investigations: tools and patterns in California as a case study for endemic shigellosis.

Authors:  Sawsan Al-Nimri; Woutrina A Miller; Barbara A Byrne; Gerry Guibert; Lily Chen
Journal:  BMC Infect Dis       Date:  2009-11-24       Impact factor: 3.090

9.  Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010.

Authors:  Bing Gu; Xing Ke; Shiyang Pan; Yan Cao; Ling Zhuang; Rongbin Yu; Huimin Qian; Genyan Liu; Mingqing Tong
Journal:  J Biomed Res       Date:  2013-02-28

10.  Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.

Authors:  Yves T Barogui; Sandor Klis; Honoré Sourou Bankolé; Ghislain E Sopoh; Solomon Mamo; Lamine Baba-Moussa; Willem L Manson; Roch Christian Johnson; Tjip S van der Werf; Ymkje Stienstra
Journal:  PLoS Negl Trop Dis       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.